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Abstract  
In the absence of extracellular stimulation the adaptor protein Grb2 and the 
phospholipase Plcγ1 compete for the same binding site on FGFR2. Reducing 
cellular Grb2 results in up-regulation of Plcγ1 and depletion of the phospholipid 
PI(4,5)P2. The functional consequence of this event on signaling pathways are 
unknown. We show that the decrease in PI(4,5)P2 level under non-stimulated 
conditions inhibits PTEN activity leading to the aberrant activation of the 
oncoprotein Akt. This results in excessive cell proliferation and tumor progression 
in a xenograft mouse model. As well as defining a novel mechanism of Akt 
phosphorylation with important therapeutic consequences, we also demonstrate 
that differential expression levels of FGFR2, Plcγ1 and Grb2 correlate with 
patient survival. Oncogenesis through fluctuation in the expression levels of 
these proteins negates extracellular stimulation or mutation and defines them as 
novel prognostic markers in ovarian cancer. 
 
Introduction  
Prolonged growth factor deprivation during tumor growth can paradoxically 
contribute to the progression of the oncogenic process1,2. Indeed, depletion of 
mitogenic signals through serum starvation has been shown to induce excessive 
proliferation in cancer cells2-7. Under these ‘basal’ conditions, non-homeostatic 
signaling has been linked to tyrosine kinases including fibroblast growth factor 
receptor 2 (FGFR2) even in the absence of autocrine/paracrine response8-10. 
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However, the exact mechanism and underlying pathways for this oncogenic 
process remain elusive.  
FGFR2 is vital for normal cellular processes but can also induce 
mitogenesis, angiogenesis and chemo-resistance in several types of cancer11-14. 
We previously reported that, in the absence of extracellular stimulation, growth 
factor receptor bound protein 2 (Grb2) and phospholipase C gamma 1 (Plcγ1) 
compete for the same binding site on FGFR2 to regulate cellular homeostasis 
and the membrane lipid pool. Under conditions of Grb2 depletion, Plcγ1 binds to 
FGFR2 and is aberrantly activated in a tyrosyl phosphorylation-independent 
manner leading to the excessive hydrolysis of its plasma membrane-localized 
phosphatidylinositol 4,5, bisphosphate (PI(4,5)P2) substrate10. PI(4,5)P2 is critical 
for recruitment of effector molecules and normal cellular processes15,16 but the 
mechanisms of aberrant signaling resulting from fluctuation in the membrane 
pool of PI(4,5)P2 remain poorly understood. Thus, whether variations in the 
PI(4,5)P2 level contribute to FGFR2-mediated oncogenic outcome remains an 
open question. 
One of the main signaling pathways linked to PI(4,5)P2 concentration is 
the PI3K-Akt pathway which mediates survival and proliferation and can be 
aberrantly activated in an array of cancers17. This pathway is driven by the 
activity of class I phosphatidylinositol 3-kinases (PI3Ks) which phosphorylate 
PI(4,5)P2 to produce phosphatidylinositol 3,4,5-triphosphate (PI(3,4,5)P3)18 which 
in turn recruits a discrete set of pleckstrin homology (PH) domain-containing 
proteins to the membrane where they become activated. The main effector of this 
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pathway is the serine/threonine protein kinase Akt which is activated on 
recruitment to the membrane localised PI(3,4,5)P319,20. The activity of PI3K is 
antagonized by phosphatase and tensin homologue deleted on chromosome 10 
(PTEN) which dephosphorylates PI(3,4,5)P3 to PI(4,5)P2 (Supplementary Figure 
1a) and can be conformationally affected by its lipid product PI(4,5)P221,22.  
Hyperactivation or loss-of-function of the key proteins in the 
PI3K/PTEN/Akt pathway contribute to cancer development and they are 
frequently deregulated in gynecologic malignancies23-27. For example, the 
phosphorylation level of the oncoprotein Akt is an indicator of the response or 
resistance to therapy in ovarian cancer26. Interestingly FGFR2 expression is also 
implicated in the progression of this gynecological cancer responsible for the 
highest mortality rate of all types of female reproductive cancer13. However the 
connection between FGFR2 expression and Akt activation remain poorly 
understood. These observations raise the question as to whether it is possible for 
Akt to be activated via FGFR2 in the absence of mitogens through the previously 
observed perturbation of levels of phospholipids. If so what are the underlying 
mechanism and functional effects? And how does the expression of FGFR2, 
Grb2 and Plcγ1 correlate with level of Akt phosphorylation? 
In this study we show that Grb2 depletion in non-stimulated cells leads to 
the inhibition of PTEN by drastically decreasing the levels of PI(4,5)P2 which 
results in the phosphorylation and activation of Akt. These findings support the 
notion that mitogens are not the sole regulators of the Akt pathway28,29 but that 
fluctuation in the expression levels of FGFR2, Grb2 and Plcγ1 are also 
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competent in this role. Our findings demonstrate that variations in the levels of 
these proteins that influence membrane lipid concentration can modulate 
proliferation in cell lines and tumor formation in a xenograft mouse model. This 
novel mechanism occurring in our model cell line translates to ovarian cancer cell 
lines and to patient samples in which FGFR2, Grb2 and Plcγ1 concentrations 
correlate with Akt phosphorylation and clinical outcome. Therefore respective 
concentrations of these proteins provide novel prognostic markers of patient 
survival.  
 
Results 
Grb2-depletion in serum starved, FGFR2-expressing cells increases colony 
formation 
Human embryonic kidney cells (HEK293T) represent an ideal initial model 
system to test receptor specificity because they lack endogenous FGFR2 (see 
parental HEK293T cells; Supplementary Figure 2a). We used these cells either 
untransfected (parental HEK293T cells: negative controls), or transfected with 
GFP-FGFR2 (Supplementary Figure 2a and b show the efficiency of transfection 
and knockdown for all cells adopted in this work) at an expression level that 
mimics that of FGFR2-dependent cancer cells9. By knocking down Grb2 in 
FGFR2-expressing cells (G2i cells) anchorage-independent colony formation 
was dramatically increased (in number and size imaged under the same scale) 
compared to control cells with scrambled shRNA (Ci cells). This effect was 
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completely abrogated in FGFR2-expressing cells with Plcγ1 knocked down (Pγi 
cells) and in FGFR2-expressing cells with Grb2/Plcγ1 double knockdown (DKD) 
(Figure 1a and b). The observed proliferative outcome was shown to be FGFR2-
dependent since in the parental HEK293T cells (PCi) and parental HEK293T 
cells with Grb2 or Plcγ1 knocked down (PG2i, PPγi respectively) colony 
formation was negligible compared to FGFR2-expressing cells (Figure 1a and b). 
The lack of involvement of the kinase activity of FGFR2 was confirmed after 
treating the cells with SU5402 (FGFR2 kinase inhibitor). We observed that in the 
absence of receptor kinase activity the level colony formation was unaffected in 
G2i cells (Figure 1c and d and Supplementary Figure 2c for inhibition efficiency). 
Thus a link between Grb2 and Plcγ1 concentrations (in the presence of FGFR2) 
and colony formation appears to exist under basal conditions. Colony formation 
after FGF9 stimulation of Ci and G2i cells resulted in a comparable number of 
colonies between the two cell lines where phosphorylation of extracellular signal-
regulated kinase (Erk; aka. MAPK) was used to detect efficient stimulation 
(Supplementary Figure 2d and e). 
Akt activation is responsible for basal state colony formation 
Cell proliferation in oncogenesis is broadly attributable to aberrant signaling in 
either the mitogen-activated protein kinase (MAPK) pathway or the PI3K/Akt 
pathway. Phosphorylation of Erk is a downstream marker of MAPK signal 
activation. Under conditions of serum starvation Erk phosphorylation was 
negligible in Ci and G2i cells31 (also see Supplementary Figure 2e) confirming 
the absence of stimulation from growth factors in our culture medium. 
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Furthermore colony formation under serum starvation is independent of the 
MAPK pathway, since addition of the potent Mek (aka. MAPKK) inhibitor U0126 
had no effect on colony formation (Figure 1c and d and Supplementary Figure 2f 
(for U0126 inhibition efficiency)). It has been previously reported that cross-talk 
exists between the MAPK pathway and the PI3K pathway which affects Akt 
phosphorylation and activity32. This experiment rules out such an effect, since 
U0126 had no effect on Grb2-dependent Akt phosphorylation (Supplementary 
Figure 2f).  
In the absence of evidence for MAPK signaling as a mediator of the 
effects of knockdown of Grb2, we focused our attention on the PI3K/Akt pathway. 
Treatment with Wortmannin (PI3K inhibitor) or PH domain-dependent Akt 
inhibitor VIII drastically impeded colony formation in both Ci and G2i cells. This 
effect was opposite to the one obtained through treatment with the inhibitor of the 
pathway antagonist PTEN, SF1670 (Figure 1c and d and Supplementary Figure 
2g-i for inhibition efficiency). Interestingly, in all of these cases Akt 
phosphorylation was higher in G2i cells versus Ci cells under basal conditions. 
Also normalized reverse phase protein array (RPPA) results (Figure 1e, 
Supplementary Figure 2j (before normalization) and Supplementary Table 1) 
show that the phosphorylation level of Akt (on serine 473 and threonine 308) is 
high in the basal state compared to the stimulated state in G2i versus Ci cells. 
This was reflected in the phosphorylation level of the downstream effectors of Akt 
like glycogen synthase kinase 3 (GSK3), p70 S6 kinase (p70S6K) and 
mammalian target rapamacyin (mTOR) (Figure 1e, Supplementary Figure 2j and 
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Supplementary Table 1). The RPPA results also validate the previous 
observation that Erk phosphorylation is not the driver of colony formation in G2i 
cells. Thus, Akt phosphorylation is dependent on Grb2 concentration. This is 
further validated through a rescue study knocking in Grb2 (Supplementary Figure 
3a). In order to detect whether Akt phosphorylation negatively correlates with 
Grb2 expression levels in other cell lines, we investigated two additional FGFR2-
expressing cancer cell lines (i.e. human colon adenocarcinoma cell line (LoVo) 
with an endogenously low level of Grb2 and a rat osteosarcoma-derived cell line 
in which we depleted the Grb2 concentration (ROS17/2.8, Ci or G2i)). These 
cells showed the same Grb2-dependent Akt phosphorylation trend as our model 
cell line (Supplementary Figure 3b). Interestingly knocking down Plcγ1 
decreased pS473 (Supplementary Figure 3c) indicating that the concentration of 
Plcγ1 is also a contributor to the phosphorylation event observed.  
By performing an in vitro kinase assay using a GSK3 fusion protein as a 
substrate for the enzyme, we observed that Akt activity was higher in G2i cells 
versus Ci cells and was abolished in Pγi cells (Figure 1f and Supplementary 
Figure 3d). Wortmannin and U73122 (Plcγ1 inhibitor) unlike SF1670 treatment 
decreased Akt activity while U0126 had no significant effect. Therefore Akt is 
phosphorylated and activated in the absence of extracellular stimulation and is 
responsible for anchorage independent growth in this model. This event is 
enhanced by knocking down Grb2 or inhibiting PTEN and diminished by 
knocking down Plcγ1, inhibiting Plcγ1 or inhibiting PI3K. It is thus essential to test 
whether the previously reported concentration-dependent competition between 
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Grb2 and Plcγ1 for FGFR2 binding10 is affecting the activity of PI3K and/or PTEN 
leading to the observed effect. 
Up-regulation of PI3K activity is not required for Akt phosphorylation, 
activation and subsequent colony formation 
Upon stimulation PI3K is activated through binding to receptors either directly or 
via Grb233 and other linker molecules. To test whether the Grb2 knockdown 
results in a generalized or membrane associated increase in PI3K activity in the 
basal, non-stimulated state, we first established that the expression level of PI3K 
in both Ci and G2i cells was similar (Figure 2a, upper western blot). We then 
investigated PI3K activity in Ci and G2i cells using a competitive ELISA assay to 
measure the PI3K-mediated production of PI(3,4,5)P3 from PI(4,5)P2 (Figure 2b 
and Supplementary Figure 3e-h) in which the absorbance measured at 450nm is 
inversely proportional to the amount of lipid produced. A standard curve was 
generated utilizing serial dilutions of PI(4,5)P3 to determine the concentration of 
the lipid produced in each sample (Supplementary Figure 3e and f). The PI3K 
used in the assay was immunoprecipitated from FGFR2 transfected HEK293T 
cell lysates or membrane fractions to limit the experiment to the membrane 
localized pool of the enzyme. Wortmannin was used as an additional control for 
the specificity of the assay where Akt phosphorylation was the readout for the 
inhibition efficiency (Figure 2a, lower western blot). The amount of PI(3,4,5)P3 
produced in non-stimulated Ci and G2i total cell lysates, or the membrane 
fraction specifically was similar and hence independent of the level of Grb2 
expression (Figure 2b, and Supplementary Figure 3g and h). Another method 
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was used to test PI3K activity in Ci and G2i cell lysates via [32P]PI(3,4,5)P3 
production from unlabeled, ‘cold’ PI(4,5)P2 and [γ-32P]ATP. The level of the 
product generated after background subtraction was similar in both cell lines 
(Figure 2c). Furthermore the product was depleted upon addition of Wortmannin, 
demonstrating that the results obtained are specific to PI3K activity. We can 
therefore conclude that PI3K has a basal level of activation in non-stimulated 
cells, but an increase in membrane associated PI3K activity is not required for 
the increased colony formation observed in the absence of Grb2.  
Based on these observations, it might be assumed that the endogenous 
level of membrane localized PI(3,4,5)P3 which recruits and activates Akt 19,20 is 
not influenced by Grb2 depletion. However, this was not the case since after 
transfecting Ci and G2i cells with an empty mCherry or mCherry-Akt-PH vector 
(Supplementary Figure 4a), we observed a dramatic enhancement in the 
localization of the Akt PH domain on the membrane of G2i cells versus Ci cells 
(Figure 2d). In both cases GFP-FGFR2 was utilized as a membrane marker. We 
confirmed these results by performing a cell fractionation experiment in Ci and 
G2i cells where actin was used as a cytoplasmic marker and FGFR2 as a 
membrane marker (Figure 2e (western blot and histogram)). A larger population 
of Akt was found in the membrane of G2i cells compared to Ci cells. 
Accumulation of Akt on the membrane in Grb2 knockdown cells is driven by an 
increase in the pool of PI(3,4,5)P3, however we have shown that the increase in 
the PI(3,4,5)P3 pool is not dependent on differential PI3K activity. To 
demonstrate this we investigated phosphoinositide-dependent protein kinase 1 
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(PDK1), which is another protein that binds to membrane phospholipid 
PI(3,4,5)P3 in order to phosphorylate its substrate Akt. Upon binding to the 
membrane PDK1 is autophosphorylated on serine 241, which is required for its 
activation34. We found that PDK1 was indeed more highly phosphorylated in G2i 
cells compared to Ci cells (Figure 1e, Supplementary Figure 2j, Supplementary 
Figure 4b and Supplementary Table 1). This corroborated the notion that Grb2 
depletion is causing an accumulation of PI(3,4,5)P3 in a PI3K-independent 
manner.  
To validate this theory and also to determine the underlying causes of 
such an event, we quantified the cellular concentration of PI(3,4,5)P3 and the 
main phospholipids from which it is derived. Using mass ELISA, we measured 
PI(3,4)P2 (which is also a product of PI3K and an Akt membrane binding site), 
PI(4,5)P2 and PI(3,4,5)P3 levels in Ci and G2i cells following lipid extraction 
(Figure 2f and Supplementary Figure 4c-e for the controls and standard curves). 
We observed that the PI(3,4)P2 level is similar in the two cell lines unlike the 
PI(3,4,5)P3 level which was considerably higher in the absence of Grb2. The 
PI(4,5)P2 level however dropped significantly in G2i cells reflecting the previously 
reported Plcγ1 constitutive activation in Grb2 depleted cells10. Hence, in this work 
we show that the concentration of PI(3,4,5)P3 is affected by a Grb2-dependent 
mechanism under basal conditions. This perturbation has important 
consequences on the cellular localization of Akt and its concomitant 
phosphorylation and activation in the absence of extracellular stimulation. 
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Depletion of Grb2 leads to down-regulation of PTEN and accumulation of 
PI(3,4,5)P3 under non-stimulated conditions 
Using the SF1670 inhibitor, we have shown that PTEN in Ci and G2i cells 
abrogates colony formation and decreases Akt phosphorylation and activity 
(Figure 1c, d and f, Supplementary Figure 3h). This led us to postulate that the 
cause of PI(3,4,5)P3 accumulation could lie in the decrease in the activity of its 
key phosphatase PTEN which is equally expressed in Ci and G2i cells as 
determined by western blot analysis (Figure 3a). To test this hypothesis and 
measure PTEN activity, we utilized TLC to validate the ELISA results obtained in 
Figure 2f and to measure the intracellular levels of membrane lipids in serum 
starved radiolabeled cells. This was the method of choice since other 
approaches like mass spectrometry are limited by the distribution and operational 
pools of phospholipids and can lead to lipid decomposition35. They also require 
spiking with a known concentration of lipids, which can affect the measured lipid 
phosphatase activity of proteins36. After extraction, separation and determination 
of retention value (Rf value)-based identification of labeled phospholipids by TLC, 
we observed accumulation of PI(3,4,5)P3 in non-stimulated G2i cells but not in Ci 
cells (Figure 3a and b).  
Using EM spatial mapping37,38 (Figure 3c and d) also revealed PI(3,4,5)P3 
accumulation and PI(4,5)P2 depletion in G2i cells compared to Ci cells 
expressing non-fluorescently tagged FGFR2. Images obtained are representative 
of Ci and G2i plasma membrane sheets with anti-GFP gold particles targeted 
against GFP-tagged lipid probes. The efficiency of transfection of GFP-PH-Plcδ 
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(for specific labelling of PI(4,5)P2) or GFP-PH-Akt (for specific labelling of 
PI(3,4,5)P3) is shown in Supplementary Figure 5a and b). Gold particle spatial 
patterns were analyzed using univariant K functions to quantify the extent of 
clustering of the point pattern which reflects signaling intensity and hence in this 
case potential intracellular Akt activation. The results showed more clustering of 
PI(3,4,5)P3 in G2i cells compared with Ci cells. The opposite results were 
obtained for PI(4,5)P2 (Supplementary Figure 5c and d).  
After confirming the perturbation in the level of membrane lipids, we tested 
the level of activity of endogenous PTEN in Ci and G2i cells. The radiolabelled 
lipid substrate [32P]PI(3,4,5)P3 was prepared from ‘cold’ PI(4,5)P2 and [γ-32 
P]ATP using purified active PI3K (starting material shown in the origin of TLC on 
Figure 3e). This experiment measures the basal rate of PI(3,4,5)P3 
dephosphorylation to generate PI(4,5)P2 which, unlike the stimulation rate, is lipid 
concentration-dependent and not time-course (kinetics)-dependent. We noticed 
that in G2i cell lysates incubated with [32P]PI(3,4,5)P3 the ability of PTEN to 
restore the levels of PI(4,5)P2 was attenuated. This was reflected by the 
reduction in the PI(4,5)P2/PI(3,4,5)P3 ratio in untreated G2i cells compared to Ci 
cells (Figure 3e and f). This apparent increase in PI(3,4,5)P3 in G2i cells was 
shown to be dependent on PTEN by the addition of the PTEN selective inhibitor 
SF1670. The qualitative effect seen on the TLC plate was higher for G2i cells 
compared to Ci cells, which have more PTEN activity. Hence Ci cells were less 
sensitive to inhibitors than G2i cells. However after taking the ratio of product to 
substrate into consideration to correct for potential variability of total loaded 
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material, the relative effect of the inhibitor was similar in both cell lines (Figure 
3f). 
How is PTEN activity down-regulated under serum starvation and Grb2 
depletion? Is PI(4,5)P2, which has been previously reported to trigger a 
conformational change in PTEN22, the key regulator of its phosphatase activity 
under these conditions?  We had previously shown that the reduction in Grb2 
concentration elevates constitutive Plcγ1 activity and dramatically reduces 
cellular PI(4,5)P210. In order to test whether Plcγ1 is a regulator of PTEN activity 
in Grb2-depleted cells, we treated our cells with the phospholipase inhibitor 
U73122 (Figure 3f and g). The ratio of [32P]PI(4,5)P2/[32P]PI(3,4,5)P3 reflecting 
PTEN activity was drastically increased in G2i cells unlike Ci cells, possibly due 
to its initial elevated level in the latter. To confirm that the effect obtained is 
indeed due to Plcγ1 activity, we overexpressed it in Ci cells (Figure 3g, upper left 
panel). We then incubated the serum starved, untransfected and transfected cell 
lysates with radiolabeled [32P]PI(3,4,5)P3 (Figure 3g, lower left panel). The ratio 
of [32P]PI(4,5)P2/[32P]PI(3,4,5)P3 obtained via pixel quantification on TLC 
reflected more than a 50% decrease in PTEN activity upon Plcγ1 
overexpression.  
To test the direct effect of PI(4,5)P2 on PTEN activity, we incubated 
purified PTEN protein with labeled [32P]PI(3,4,5)P3 in the absence, or presence of 
non-labeled PI(4,5)P2. [32P]-labeled lipids were separated and visualized on TLC, 
followed by pixel quantification and statistical analysis (Figure 3h and i). In the 
absence of PI(4,5)P2, PTEN’s ability to dephosphorylate [32P]PI(3,4,5)P3 into 
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[32P]PI(4,5)P2 was weak. However, adding ‘cold’ PI(4,5)P2 at a physiologically 
effective concentration21 dramatically enhanced PTEN activity as it 
dephosphorylated the [32P]PI(3,4,5)P3 to produce [32P]PI(4,5)P2, i.e. the ratio of 
labeled [32P]PI(4,5)P2/[32P]PI(3,4,5)P3 was increased. Since the presence of 
PI(4,5)P2 activates PTEN, it follows that the PI(4,5)P2 concentration is a critical 
regulator of this tumor suppressor in the absence of extracellular stimulation.  
Reducing cellular expression level of Grb2 enhances tumor formation  
Tumor progression is known to be a multistep process in which an 
increase in tumor mass occurs concomitant with growth factor deprivation prior to 
invasion, angiogenesis and metastasis1. Our FGFR2-expressing, Grb2-depleted 
model cell line successfully formed colonies in an anchorage-independent 
manner via Akt activation. We subsequently investigated whether fluctuations in 
protein concentrations will modulate the potential to form tumors in a xenograft 
mouse model. To test this we subcutaneously injected PCi, PG2i, Ci and G2i 
cells in the right flank of adult female nude mice (4 mice per group). After 60 days 
the mice were subjected to MRI scanning (coronal and axial sections) to 
characterize tumor formation (Figure 4a). Mice injected with G2i cells showed 
higher tumor weight and volume with excessive multi-nodular burden compared 
to mice injected with Ci or PG2i cells. PCi injection failed to develop noticeable 
tumors (Figure 4a and b). Grb2 depletion results in the development of multiple 
tumors in the vicinity of the primary tumor indicating infiltration, invasion and/or 
local metastasis of tumor cells into the surrounding tissue. These results are 
consistent with our data from the colony formation assay performed under serum 
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restriction where G2i cells were unique in their ability to proliferate into multiple 
colonies of increased size. Morphologically the G2i tumor is composed of similar 
types of neoplastic cells as Ci tumor but shows more anaplastic or higher degree 
of cellular pleomorphism (Figure 4c) characteristic of Akt pathway alteration39. 
Compared to Ci cells, G2i cells have lower amounts of cytoplasm and the nuclei 
have severely coarse, stippled or clumped chromatin with prominent multiple 
nucleoli and mitotic figures (as shown by the black arrows). Large areas of 
necrosis affected approximately 60-70% of the entire G2i tumor compared to 5-
10% in Ci tumors (Figure 4c). The margins of the G2i tumor are indistinct and 
there is infiltration of tumor cells into the mammary tissues, fibroadipose tissue 
and skeletal muscles unlike Ci and PG2i tumors (as shown by the arrows in 
Figure 4c and d).  
To determine if Akt activity is increased in the G2i subcutaneous tumors, 
we stained for pAkt. G2i cells stained positive consistent with the increases in 
mitotic progression and proliferation (Figure 4e, left panel). Tumor cells in the 
perivascular areas have increased pAkt staining in comparison with tumor cells 
that are further away from the blood vessels (depicted with a black arrow). 
Conversely the Ci tumor cells showed negligible staining with the pAkt (S473) 
antibody. Therefore, tumor tissues depleted for Grb2 exhibit the hallmarks of 
elevated Akt signaling. In western blot analysis of Ci and G2i tumors (Figure 4e, 
right panel), G2i tumors showed a higher level of Akt phosphorylation compared 
to Ci tumors. Total Akt and actin were used as loading controls. These results 
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emphasize the dependence of tumor progression on respective G2i protein 
concentration. 
FGFR2, Grb2 and Plcγ1 are modulators of Akt and predictive markers in 
ovarian cancer  
 Akt is highly phosphorylated and activated in ovarian cancer conversely 
dephosphorylation is known to limit tumor growth40. We performed IHC staining 
on an ovarian cancer patient tissue microarray (TMA) and observed an increase 
in Akt phosphorylation, which correlated with higher grade tumor and poorer 
prognosis (Figure 5a). Interestingly, database analysis of clinical information 
downloaded from Cancer Genome Atlas Project (TCGA; http://tcga-
data.nci.nih.gov/) and Tothil et al., 200841 (Figure 5b and Supplementary Figure 
6b-e) revealed that low levels of FGFR2 mRNA and Plcγ1 mRNA with a 
concomitantly high level of Grb2 mRNA is associated with a favorable prognosis 
as opposed to cases with high FGFR2, high Plcγ1 and low Grb2 mRNA levels. 
This mirrors the results obtained with cell lines and xenograft mouse models.  
To establish a better understanding of this we utilized 2 ovarian cancer 
cell lines, OVCAR3 and OVCA433. The latter expresses higher levels of Grb2, 
which in the background of lower levels of FGFR2 and Plcγ1 expression resulted 
in more Grb2 being immunoprecipitated by FGFR2 (i.e. enhanced Grb2-FGFR2 
complex formation), than OVCAR3 cells (Figure 5c and d and Supplementary 
Figure 6a). Also, unstimulated OVCA433 showed lower levels of Akt 
phosphorylation compared to OVCAR3 (Figure 5e). Interestingly, overexpression 
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of Grb2 in OVCAR3 cells resulted in an increase in PI(4,5)P2, a decrease in 
PI(3,4,5)P3 and a stable PI(3,4)P2 level (Figure 5f and g and Supplementary 
Figure 4c-e) consistent with the results obtained in Ci and G2i cells. The 
decrease in PI(3,4,5)P3 and pAkt were accompanied by a significant drop in 
colony formation in 3D culture under serum starvation conditions (Figure 5h and 
j). The 3D cultured cells were stained with Ki-67 (a marker of proliferation 
expressed in growth phase but absent in the resting phase), which was more 
prominent in the nucleus of untransfected cells (Figure 5i and j). This provides 
further evidence of Grb2-mediated cellular proliferation via Akt phosphorylation in 
the context of FGFR2.  
Finally, we investigated the correlation between FGFR2, Grb2 and Plcγ1 
protein expression (as one event) with patient survival using IHC staining of 
TMAs. Low FGFR2/low Plcγ1/high Grb2 correlated with favorable survival in 
contrast to high FGFR2/high Plcγ1/low Grb2 (Figure 5K and representative 
images of staining in Figure 5l). This confirms the results obtained via analysis of 
mRNA levels in the TCGA and in ovarian cancer cell lines. Interestingly, when 
TMAs were stained for pAkt (Figure 5l), low FGFR2/low Plcγ1/high Grb2 
correlated with lower score of pAkt staining unlike high FGFR2/high Plcγ1/low 
Grb2 (Figure 5m).  
Discussion  
The role of growth factor deprivation in the modulation of signaling 
pathways is poorly understood or appreciated. Under these conditions, FGFR2 is 
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capable of regulating cellular functions through competitive binding between 
Grb2 and Plcγ110. Here we investigated whether variations in FGFR2 levels and 
binding to Grb2 and Plcγ1 can activate other signaling pathways and induce 
additional oncogenic effects under growth factor deprivation via Grb2-Plcγ1 
competition. In this study we show that proliferation is driven by a mechanism 
initiated in FGFR2-expressing cells independent of extracellular stimulation. This 
outcome is solely dependent on changes in protein concentrations and the 
resultant fluctuation in the levels of membrane phospholipids leading to Akt 
pathway regulation. To provide an appropriate pool of phospholipid for Akt 
recruitment a balance between lipid kinase and phosphatase activity is essential, 
thus perturbation of the activation of either of these enzymes can either promote 
or depress the onset of a proliferative signal. Here we also show that Grb2 
depletion, by promoting Plcγ1 activity, limits PI(4,5)P2-dependent PTEN activity. 
As a result PI(3,4,5)P3 is not converted to PI(4,5)P2 and thus accumulates in the 
plasma membrane. This leads to the consequent recruitment and activation of 
Akt in the absence of extracellular stimulation (Supplementary Figure 1a and b). 
Thus, Grb2-Plcγ1 competition can negate the need for mitogen-dependent 
activation of signaling pathways by regulating the levels of phospholipids 
primarily through decreased PTEN activity. Under these conditions cells are 
highly effective in modulating anchorage-independent colony formation in culture. 
This is reflected in tumor progression in a xenograft mouse model and a 
correlation with survival in ovarian cancer patients. Thus, investigating signaling 
pathways and their functional effects under non-stimulatory conditions, which 
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mimic early phases of cancer progression, is essential to understanding tumor 
development. In this case, the relative concentrations of Grb2 and Plcγ1 in 
FGFR2-expressing tumor cells provide a significant predictive marker for tumor 
staging and oncogenic outcome that could prove critical for therapeutic decision 
making. 
 
Materials and methods 
Cell culture. All cell lines with the exception of ROS17/2.8 osteosarcoma cells 
were cultured in Dulbecco’s modified Eagle’s high glucose medium (DMEM). The 
former was grown in phenol red-free DMEM. DMEM was supplemented with 10% 
(vol/vol) fetal bovine serum (FBS) and 1% antibiotic/antimycotic (Lonza) in a 
humidified incubator at 37°C with 10% CO2. Cells expressing GFP fused to the 
C-terminus of FGFR2 and the knockdowns were produced as previously 
described9,10,43.  
PI(3,4,5)P3 phosphatase assays. Unilamellar liposomes containing radiolabeled 
substrate lipid in a background of phosphatidylserine were used to assay lipid 
phosphatase (PTEN) activity by modifying the described protocol44. 
PI3K assay by thin layer chromatography. The activity of PI3K was measured via 
competitive ELISA (following the manufacturer’s instructions) and through 
monitoring PI(4,5)P2 phosphorylation  using γ[32P]ATP as co-substrate by 
modifying the described protocol45.  
EM-spatial mapping was carried out as previously explained38 . 
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Xenograft mouse model magnetic resonance imaging (MRI) and IHC staining 
were performed as required by MD Anderson small animal imaging facility. 
Clinical data analysis is detailed in the Supplementary Materials. 
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Figure Legends 
Figure 1. Akt pathway-dependent colony formation is enhanced in Grb2 
knockdown cells  
(a) HEK293T cells with and without FGFR2 were transfected with scrambled 
shRNA, Grb2 shRNA and/or Plcγ1 shRNA to generate stable knockdowns: PCi, 
PG2i and PPγi for parental cells, and Ci, G2i, Pγi and Grb2/Pγi (double 
knockdown, DKD) for cells transfected with GFP-FGFR2.  0.6 x 104 cells were 
cast as a single cell suspension in serum-deprived DMEM/agar in the upper layer 
with DMEM/agar with 1% FBS in the lower layer. Cells were left to grow for 8 
days. DMEM with 1% FBS was added to the wells once every seven days. 
Pictures of the entire wells were taken. Pictures of colonies made from Ci or G2i 
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cells transfected with GFP-FGFR2 were taken at 20X magnification to show the 
difference in colony size formed.  
(b) Colonies formed in each case in (a) were counted and averaged in 4 
microscopic fields (independent experiments n=3). Error bars on the graph 
represent the standard deviation of the calculated mean. Student’s t-test 
indicates p≤ 0.01 which denotes a significant increase in the number of colonies 
formed upon Grb2 depletion in FGR2 expressing cells.  
(c) Same as (a) but in this case DMEM with 1% FBS in the presence of the 
indicated inhibitors was added to the relevant wells once every seven days. Only 
cells transfected with GFP-FGFR2 (Ci and G2i cells) were utilized. See also 
Supplementary Figure 2c, f-I for efficiency of inhibition. 
(d) Colonies formed in each case in (c) were counted and averaged in 4 
microscopic fields (independent experiments n=3). Error bars on the graph 
represent the standard deviation of the calculated mean. Student’s t-test 
indicates *p≤ 0.05 and **p≤ 0.01. 
(e) Heat map was generated via the R console statistical package. It summarizes 
the normalized linear RPPA values of the results obtained using 3 independent 
samples from Ci and G2i cells (unstimulated or stimulated with FGF9) as 
explained in the Supplemental Experimental Procedures section. See also 
Supplementary Figure 2j and Supplementary Figure 3a-c. 
(f) Results of Akt in vitro kinase assay utilizing immunoprecipitated Akt (with 
purified GSK3α/β as a substrate) are shown in a western blot. The experiment 
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was carried out in the presence (+) or absence (-) of the indicated inhibitors. The 
membrane was probed with the indicated antibodies where anti-Total Akt was 
used as a control. Numbers on the blot represent densitometric analysis results 
in arbitrary units. See also Supplementary Figure 3d. 
Figure 2. PI(3,4,5)P3 is generated equally by PI3K in Ci and G2i cells yet Akt 
membrane localization is enhanced in the latter 
(a) Upper western blot: Ci and G2i cells were serum starved and utilized for 
western blot analysis to detect the expression level of PI3K. Lower western blot: 
Untreated or Wortmannin treated cells (to ensure PI(3,4,5)P3 production is PI3K 
mediated) were used for western blot with pAkt as readout for inhibition 
efficiency. 
 (b) Left panel: PI3K was immuno-precipitated from untreated or Wortmannin 
treated cells on agarose beads using a PI3K specific antibody and used in a 
competitive ELISA assay. Absorbance at 450 nm was measured for samples run 
in triplicates (n=3) and used to extrapolate the amount of PI(3,4,5)P3 produced in 
each case (See  Supplementary Figure 3e-h ). Values were normalized against 
“untreated Ci” sample. Error bars denote standard deviation of the mean. 
Student’s t-test indicates ***p≤ 0.001. Right panel: Same PI3K assay but in this 
case serum starved untreated Ci and G2i cells were subjected to fractionation 
first and only the membrane fraction was utilized in the experiment as an 
additional control to specifically quantify the membrane pool of PI(3,4,5)P3. The 
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differences obtained were not statistically significant as determined by Student’s 
t-test. 
(c) Untreated or Wortmannin-treated cell lysates from Ci and G2i cells were used 
to detect the activity of intracellular PI3K by incubating fresh cell lysate with 
[32P]ATP and unlabeled PI(4,5)P2. The [32P]PI(3,4,5)P3 that was generated by 
PI3K was detected by TLC. Results of [32P] labeled lipids were visualized and 
quantified for adjusted volume as shown on the representative image. 
(d) Ci and G2i cells transfected with an empty mCherry vector or mCherry-Akt-
PH vector were serum starved and used for microscopy as explained in the 
Supplemental Experimental Procedures section. FGFR2-GFP was used as a 
membrane marker to show co-localization of the lipid binding PH domain on the 
membrane. Scale bar: 10 µm for empty mCherry vector and 25 µm for mCherry-
Akt-PH vector. See also Supplementary Figure 4a for transfection efficiency. 
(e) Top panel: serum starved Ci and G2i cells were fractionated into membrane 
and cytoplasmic portions and used for Western blot analysis then probed with the 
indicated antibodies followed by densitometric analysis. Bottom panel: graphical 
display of the quantified ratio of membrane total Akt to total FGFR2 (from 3 
independent fractionation experiments) to show the increased Akt localization on 
the membrane. The red numbers on the blot presented in arbitrary units 
represent the ratio of total Akt to FGFR2 (the membrane marker). 
Error bars denote standard deviation of the mean. Student’s t-test was used to 
assess statistical significance *p≤ 0.05. 
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(f) Absorbance at 450 nm (assays are explained in the Supplementary 
Experimental Procedures section and shown in Supplementary Figure 4c-e) was 
used to extrapolate the amount of PI(3,4)P2, PI(4,5)P2 or PI(3,4,5)P3 produced. 
Values were averaged and normalized against Ci cells. Error bars denote 
standard deviation of the mean. ***p≤ 0.001 indicates a significant decrease in 
PI(4,5)P2 with a concomitant increase in PI(3,4,5)P3 in G2i cells compared to Ci 
cells. 
Figure 3. PTEN activity is significantly reduced upon Grb2 depletion due to 
excessive PI(4,5)P2 hydrolysis via Plcγ1 
(a) Top panel: Western blot analysis was utilized to detect PTEN expression level 
in Ci and G2i cells. The blot was probed with the indicated antibodies. Bottom 
panel: Ci and G2i cells growing in serum free DMEM were labeled with myo-[2-
3H(N)]inositol  and used for lipid extraction followed by TLC. PI(4,5)P2 and 
PI(3,4,5)P3 were identified based on their Rf values reported in the literature 42.  
(b) Pixel quantification results from the previous TLC were averaged from 3 
independent experiments and normalized to generate a histogram. Error bars 
denote standard deviation of the mean with a calculated **p≤ 0.01. 
(c) Representative images of EM spatial mapping show the number of anti-GFP 
gold particles (and hence respective lipid concentrations) with a scale bar of 200 
nm (for a 1μm x 1μm square). Ci and G2i cell lines were both transfected with 
GFP tagged lipid probes. See also Supplementary Figure 5a and b for 
transfection efficiency. 
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(d) At least 12 plasma membrane sheet images from (C) were acquired. The 
mean and standard error of the mean for the number of gold particles were 
calculated for each condition and Student’s t-test was used to assess statistical 
significance which in both cases **p≤ 0.01. See also Figure S5C and D for 
clustering experiments performed as described in Supplementary Experimental 
Procedures section. 
(e) Cell lysates from untreated cells or cells treated with the indicated inhibitors 
were incubated with [32P]PI(3,4,5)P3 as a PTEN substrate. TLC was used for the 
separation of extracted labeled lipids as shown on the blot.  
(f) Pixel quantification data (n=3) was used to generate the bar graph showing 
the ratio of the product PI(4,5)P2 to the substrate PI(3,4,5)P3 following adjustment 
to the total amount of loaded lipid which reflects PTEN enzymatic activity. 
U73122 and SF1670 were used to depress Plcγ1 and PTEN activities 
respectively. The dramatic reduction in the PI(4,5)P2/PI(3,4,5)P3 ratio in the 
presence of SF1670 strongly suggests that the effect is specific to PTEN.  
Standard deviation of the mean is denoted by error bars. *p≤ 0.05 
(g) Top panel: Ci cells were left untransfected or transfected with Plcγ1 followed 
by western blot and densitometric analysis of band intensity. Bottom panel: Lipids 
extracted from these cells were incubated with [32P]PI(3,4,5)P3 and subjected to 
TLC to measure PTEN activity. PI(4,5)P2/PI(3,4,5)P3 ratio quantification was 
obtained from duplicate experiments visualized and quantified for adjusted 
volume (pixel percentage).  
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(h) Top panel: Purified PTEN was incubated with Ptdser and [32P]PI(3,4,5)P3 in 
the presence or absence of 33 µM of cold PI(4,5)P2. TLC was run to separate 
[32P] labeled lipids followed by visualization and pixel quantification. Bottom 
panel:  Results from three independent experiments were averaged following the 
calculation of the ratio of [32P]PI(4,5)P2  to [32P]PI(3,4,5)P3. Error bars represent 
the standard deviation of the mean. Student’s t-test was used to calculate the 
statistical significance with ***p≤ 0.001. 
Figure 4. Knocking down Grb2 in FGFR2 expressing cells enhances their 
ability to form tumors with high levels of Akt phosphorylation 
(a) Top panel: Coronal MRI representative images of PCi, PG2i, Ci, G2i cell 
injected mice were taken following 60 days of subcutaneous injections. Arrows 
indicate the tumors formed. Middle panel: Axial MRI images of PCi, PG2i, Ci, G2i 
injected mice following subcutaneous injections. White arrows indicate the 
tumors formed. Bottom panel: A representative sample from each group (4 mice 
per group) showing both size and number of tumors formed.  
(b) Upper panel (on the left): Tumor volumes were calculated in the axial sections 
obtained via MRI as explained in details in the Supplemental Experimental 
Procedures section. Results shown are the averages of the tumor volume in 
every group. Bottom panel (on the left): Tumors in every group were weighed (in 
grams) and averaged to generate a bar graph. Error bars denote standard 
deviation of the mean. Student’s t-test was used to calculate the statistical 
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significance with **p≤ 0.01. Right panel: Tumor nodules/mouse were counted 
and presented in a bar graph.  
(c) Representative images of H & E staining of Ci and G2i tumors were taken at 
40x and 600x to show infiltration to nearby tissues. Scale bars are 500 and 50 
µm respectively. Images from 600x magnification were enlarged to show cellular 
morphology. Black arrows denote the nuclear/mitotic figures in G2i cells. 
(d) Upper panels: Representative pictures of PG2i, Ci and G2i tumors (H & E 
staining) were taken at 400x magnification with a scale bar of 50 µm. Green 
arrows indicate the margins of PG2i and Ci tumors whereas black arrows (bottom 
panel) specify infiltration of G2i tumors into nearby tissues. 
(e) Left panel: Representative images of pAkt staining of Ci and G2i tumors were 
taken at 40x, 200x and 400x. Scale bars are 500,100, 50 µm respectively. Black 
arrow is showing Akt phosphorylation in the perivascular region. Right panel: 
Western blot shows the level of Akt phosphorylation in tumor sections following 
sonication and protein extraction. 
Figure 5. FGFR2, Grb2 and Plcγ1 modulate Akt phosphorylation in ovarian 
cancer and can act as prognostic markers for patient survival 
(a) Upper panel: H & E staining of representative TMA images taken at 400x with 
a scale bar of 50 µm. Lower panel: Representative images of pAkt staining were 
taken at 400x with a scale bar of 50 µm.  
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(b) Percentage survival of ovarian cancer patients is presented in a Kaplan-
Meyer curve based on the downloaded and analyzed clinical data as explicitly 
explained in the Supplemental Experimental Procedure section. The calculated 
Log-rank test value is ****p≤ 0.0001 which indicates significant correlation 
between FGFR2, Grb2 and Plcγ1 (prognostic markers) with patient survival. The 
median of overall survival (OS) in months is shown in parentheses. See also 
Figure S6. 
(c),(d) and (e) Western blot analysis was performed using OVCAR3 and 
OVCA433 cell lysates where the blots were probed with the indicated antibodies. 
The numbers in red are densitometric analysis results presented in arbitrary units 
on the blots. 
(f) OVCAR3 cells were left un-transfected or transfected with Grb2 followed by 
western blot and densitometric analysis. 
(g) Absorbance measured at 450 nm was used to extrapolate the amount of 
PI(3,4)P2, PI(4,5)P2 or PI(3,4,5)P3 produced. Values from 3 independent 
experiments were averaged and normalized against un-transfected OVCAR3 
cells. Error bars denote standard deviation of the mean. **p≤ 0.01 indicates a 
significant increase in PI(4,5)P2 with a concomitant decrease in PI(3,4,5)P3 upon 
Grb2 transfection. See also Supplementary Figure 4c-e. 
(h). Cells from (f) were utilized for 3D culture assay as described in the Materials 
and Methods section. The experiment was run in two chambers each containing 
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a triplicate of each sample. Pictures of colonies (black arrows) formed in serum 
restricted DMEM were taken at 10X and 20X magnification.  
(i) Cells from (f) were fixed and stained with the proliferation marker, Ki-67. scale 
bar is 50 µm. 
(j) Left panel: Colonies formed in (h) were counted in 4 microscopic fields, 
averaged, normalized against un-transfected cells and utilized for bar graph 
generation. Error bars represent standard deviation of the calculated mean. 
Student’s t-test was used to assess statistical significance (*p≤ 0.05). Right 
panel: Number of Ki-67+ cells were counted under same magnification, averaged 
and normalized against un-transfected cells. Error bars on the histogram 
generated denote the standard deviation of the calculated mean. Student’s t-test 
was used to assess statistical significance (**p≤ 0.01). 
(k) TMA of patients expressing FGFR2, Grb2, and Plcγ1 (IHC staining is 
described in the Supplemental Experimental Procedures) were scored and 
analyzed to generate a survival curve with log-rank test p-value <0.001. 
(l),(m) Representative images of the TMAs stained for the proteins of interest. 
were taken at 20X magnification. The results obtained were used to correlate the 
expression level of the 3 biomarkers with pAkt level as explained in the 
Supplemental Experimental Procedures. Chi square test was used to detect 
statistical significance of the correlation. p-value <0.002. 
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